Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$2.0B
17M shares
52-week range
$7.48 – $125.71
91% from low
Sector
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
Exchange
NYSE
CS
Borrow rate
0.41%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $794.4M | $1.22B | $1.52B | $2.39B | $4.32B | $6.06B | $5.93B |
| Cost of revenue | $765.9M | $1.12B | $1.46B | $2.28B | $4.25B | $6.06B | $6.12B |
| Gross profit | $28.5M | $94.2M | $65.7M | $111.4M | $69.7M | $4.8M | −$188.6M |
| Gross margin | 3.6% | 7.7% | 4.3% | 4.7% | 1.6% | 0.1% | -3.2% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$106.6M | −$56.7M | −$372.2M | −$105.4M | −$232.1M | −$292.1M | −$421.1M |
| EBITDA | −$64.2M | −$40.1M | −$362.2M | −$72.4M | −$167.6M | −$218.2M | −$368.9M |
| Net income | −$282.6M | −$60.1M | −$406.5M | −$106.6M | −$262.6M | −$260.2M | −$405.3M |
| Net margin | -35.6% | -4.9% | -26.7% | -4.5% | -6.1% | -4.3% | -6.8% |
| EPS (diluted) | -18.50 | -4.00 | -27.25 | -6.50 | -16.00 | -15.75 | -24.50 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $5.7B | $-2.84 | $-3.13–$-2.56 | 8 |
| 2027 | $6.1B | $-0.99 | $-1.39–$-0.73 | 8 |
| 2028 | $6.8B | $1.46 | $-2.57–$4.86 | 7 |
| 2029 | $7.7B | $2.91 | $2.79–$3.00 | 2 |
Forward consensus · source: Financial Modeling Prep
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
www.agilonhealth.comNo one on the platform currently holds AGL.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 149,043 | $1.2M |
| Execution date | Ratio |
|---|---|
| 2026-03-31 | 1-for-25reverse |
No one on the platform has traded AGL yet.
| $707M |
| — |
| ENGNenGene Holdings Inc. | $1.78 | +1.71% | $91M | — |
| LRMRLarimar Therapeutics, Inc. | $3.20 | -12.57% | $274M | — |
Source: Financial Modeling Prep · peers by sector/industry
@ProWesTrader @PhishTourFunds I owned agl from 25, sold second half at $111. I have no idea how it trades from here but for context, $ASTH does the same thing with better results and trades at $2.75bn EV vs expected 315mm ebitda in 27. This is my biggest position. $AGL trades at $1.8bn EV vs consensus 60mm in ebitda next year. That number is low and will need to come up, so maybe that keeps pushing the price higher. But you can see agl would need to do 200mm+ ebitda in 27 to justify its current price. That seems like a very tall order to me.
View on StockTwits ↗$AGL another 90% from here I mean…with all due respect wen short?
View on StockTwits ↗$AGL talk about MM shaking the tree.. took it down all the way to $95 to capture the stops and then ran it right back up. Don’t put stops.. if you own shares, make sure they are not being loaned out by brokers. This is going to run to $125-$150 very soon(maybe hit that before earnings)
View on StockTwits ↗$AGL green close? Citizen has a price target of $112 and that was before these guys presented there this morning.. wait for the PT upgrade
View on StockTwits ↗$AGL I still think this gets bought out sooner then later by Centene, Elevance or UNH.. adds $5.5B revenue for them at sub $2-$3B valuation
View on StockTwits ↗$AGL this one is making a pretty compelling case
View on StockTwits ↗$AGL at these levels $ASTH much better risk/reward
View on StockTwits ↗$AGL will be interesting to listen to the ACO model update on June 23rd.. hopefully they can provide so details on how they are tracking to their plan
View on StockTwits ↗$BYND the reverse split will only help this company just as it did $AGL
View on StockTwits ↗$AGL lfg! 150 incoming soon! Been waiting since the pre split at .30 for this! My ytd retirement 160%!
View on StockTwits ↗$AGL very green all day but dropped like a hot potato right at market close
View on StockTwits ↗$SPCE Watch the last 45 days of $AGL … In AGL is today .. after day, after day.. No hope.. only earning..
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Trading at 0.3× sales vs its 1.8× historical median P/S.
Fair value ≈ $666.78 · price $115.15 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.